Brooklyn Investment Group’s Merck MRK Stock Holding History

Brooklyn Investment Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.3M	Buy	85,476 +21,032	+33%	+$2.43M	0.32%	42
2025 Q4	$6.87M	Buy	64,444 +33,317	+107%	+$3.13M	0.32%	51
2025 Q3	$2.46M	Sell	31,127 -556	-2%	-$45.8K	0.33%	56
2025 Q2	$2.51M	Buy	31,683 +8,913	+39%	+$708K	0.33%	56
2025 Q1	$2.04M	Buy	22,770 +11,599	+104%	+$1.08M	0.44%	31
2024 Q4	$1.11M	Sell	11,171 -2,794	-20%	-$288K	0.33%	52
2024 Q3	$1.59M	Buy	13,965 +505	+4%	+$60K	0.52%	33
2024 Q2	$1.76M	Hold	13,460	–	–	0.76%	28
2024 Q1	$1.76M	Buy	13,460 +167	+1%	+$20.6K	0.76%	28
2023 Q4	$1.45M	Buy	+13,293	New	+$1.38M	0.69%	29

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Brooklyn Investment Group's MRK Position: Q1 2026 in Review

Brooklyn Investment Group increased its Merck (MRK) stake by 33% in Q1 2026, buying an estimated $2.43M and bringing the position to 85,476 shares worth $10.3M. The position accounts for 0.32% of the portfolio, ranked #42.

Brooklyn Investment Group first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Brooklyn Investment Group held 85,476 shares of Merck worth $10.3M as of Q1 2026.
Brooklyn Investment Group bought 21,032 Merck shares in Q1 2026, an estimated $2.43M.
Merck made up 0.32% of Brooklyn Investment Group's portfolio in Q1 2026, its #42 holding.
Brooklyn Investment Group first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.